See the DrugPatentWatch profile for yervoy

Yes, the serious side effects of Yervoy (ipilimumab) can be managed, although they can be severe and potentially life-threatening. Yervoy is a type of immunotherapy used to treat certain types of cancer, including melanoma. It works by stimulating the body's immune system to attack cancer cells. However, this can also lead to over-activation of the immune system, resulting in various side effects.

Common side effects of Yervoy include fatigue, diarrhea, skin rash, and itching. Serious side effects, which are less common but more severe, include immune-mediated side effects such as colitis (inflammation of the colon), hepatitis (inflammation of the liver), dermatitis (inflammation of the skin), neuropathy (nerve damage), and endocrinopathies (hormonal imbalances) [1].

To manage these serious side effects, it is essential to seek immediate medical attention if any symptoms occur. Doctors may prescribe corticosteroids or other medications to reduce inflammation and suppress the immune system [1]. In some cases, patients may need to discontinue Yervoy treatment or undergo hospitalization for monitoring and treatment.

It is important to note that the management of Yervoy's side effects may depend on the severity and type of side effect. Patients should work closely with their healthcare team to develop a personalized treatment plan and monitor for any side effects.

In summary, while Yervoy's serious side effects can be managed, they can be severe and potentially life-threatening. Immediate medical attention is necessary if any symptoms occur. Patients should work closely with their healthcare team to monitor for and manage any side effects.

Sources:

1. [DrugPatentWatch.com](https://www.drugpatentwatch.com/drugs/yervoy). Yervoy (ipilimumab) Prescribing Information. Bristol-Myers Squibb Company. 2021. <https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/125293s035lbl.pdf>.